Hence, the cytokine CCL11, known to also pass the intact blood-brain barrier (BBB), has recently been recognized as an interesting target under conditions of CNS diseases not limited to cerebral ischemia alone [2]. This evidence concerns the gene CCL11 and Cerebral ischemia.